Evidence for a role in energy metabolism has been demonstrated in IL-18-deficient mice, which presented diabetes mellitus and dyslipidemia, which leads to nonalcoholic fatty liver disease and steatohepatitis [18, 19, 21]. Here, IL18 is linked to metabolic syndrome.